Kenneth Cusi MD, FACP, FACE
Professor of Medicine; Chief, Division of Endocrinology, Diabetes and Metabolism, University of Florida; Acting Chief, Division of Endocrinology, Diabetes and Metabolism, Malcolm Randall Veterans Administration Medical Center, Gainesville, FloridaDr. Cusi is a Professor of Medicine and Chief of the Division of Endocrinology, Diabetes and Metabolism at The University of Florida at Gainesville (2011-present). He is also a faculty and researcher at the Endocrinology, Diabetes and Metabolism Division at the Veterans Administration Medical Center at Gainesville, FL.
Dr. Cusi has published numerous reviews, book chapters and original articles in a broad spectrum of peer-reviewed journals, such as the New England Journal of Medicine, Annals of Internal Medicine, Proceeding of the National Academy of Science, Journal of Clinical Investigation, Diabetes, Diabetes Care, J Clinical Endocrinology and Metabolism, American Journal of Physiology, Hepatology, Gastroenterology and others. He is an associate editor and reviewer for many journals in the fields of endocrinology, metabolism, diabetes and liver disease. He is a frequent invited lecturer to national and international meetings on the role of obesity and NAFLD in T2DM.
He is also co-founder and vice-president of Children in Need (www.childrenneed.org), a philanthropic organization aimed at improving the living conditions and education of children in Africa.
Disclosures
Financial Disclosures:
Research studies: Janssen, Novartis, Novo Nordisk, Octeta.
Consultant: Deuterex, Janssen, Kowa, Lilly, Novartis, Novo Nordisk, Pfizer, Teva, Tobira, ZydusRecent Contributions to PracticeUpdate:
- Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and NAFLD
- Effects of Lifestyle Interventions on Clinical Characteristics of Patients With NAFLD
- EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease
- NAFLD Is Associated With Type 2 Diabetes Risk
- MY APPROACH to NASH in Type 2 Diabetes